![]()
A) <80 mmHg B) <110 mmHg C) <100 mmHg D) <90 mmHg
A) 1.4% B) 0.14% C) 0.50% D) 0.01%
A) 50% B) 96% C) 16% D) 69%
A) 1000 μg/L B) 500 μg/L C) 50 μg/L D) 100 μg/L
A) Age plus 500 μg/L B) Age divided by 10 μg/L C) Age multiplied by 10 μg/L D) Age multiplied by 5 μg/L
A) 5% to 15% B) 50% to 60% C) 16% to 47% D) 69% to 84%
A) Erythrocyte sedimentation rate B) CT pulmonary angiography C) Right heart catheterization D) Leg ultrasound
A) It is less accurate than a blood count B) It is highly invasive C) It cannot rule out PE D) It is rarely available
A) It is significantly inferior B) It is much more expensive C) It is less sensitive D) It is non-inferior
A) It is always done before D-dimer B) It may identify other lung disorders C) It requires right heart catheterization D) It has 100% specificity
A) 69% B) 50% C) 96% D) 83%
A) It is too expensive B) It has 0% specificity C) It has limited sensitivity D) It requires contrast agent
A) To replace the need for CTPA entirely B) To provide evidence for the need for imaging C) To definitively confirm PE D) To measure lung function
A) Troponin only B) D-dimer only C) Full blood count and clotting status D) Blood pressure only
A) Age bias B) Measurement bias C) Incorporation bias D) Selection bias
A) 69% B) 83% C) 96% D) 50%
A) Red blood cell count B) Blood glucose levels C) Vitamin D levels D) Factor V Leiden mutation
A) Between 100 and 110 beats per minute B) Exactly 150 beats per minute C) Greater than 120 beats per minute D) Less than 100 beats per minute
A) More than 94% B) Exactly 90% C) Between 85% and 90% D) Less than 80%
A) No history of surgery B) No coughing up blood C) No leg swelling D) Estrogen use
A) To replace the need for clinical history B) As a confirmatory test C) As a screening test for everyone D) To diagnose lung cancer
A) 41% B) 10% C) 96% D) 80%
A) Hospital policy only B) Clinical reasoning C) Patient preference alone D) The time of day
A) No leg swelling B) No previous blood clots C) A history of trauma in the last year D) Age less than 50
A) Iliofemoral DVT B) Superficial venous thrombosis C) Distal calf DVT D) Portal vein thrombosis
A) Young men without significant risk factors B) Athletes with chronic dehydration C) Children with genetic disorders D) Elderly women with cancer
A) Pulmonary hypertension syndrome B) Chronic venous insufficiency C) Venous thromboembolism D) Arterial thrombosis
A) The VTE framework B) Virchow's triad C) The hypercoagulable model D) The clotting cascade
A) Dental surgery B) Orthopedic surgery at or below the hip C) Tonsillectomy D) Ocular surgery
A) Factor V Leiden B) Protein C deficiency C) Antiphospholipid syndrome D) Protein S deficiency
A) Antiphospholipid syndrome B) Protein C deficiency C) Paroxysmal nocturnal hemoglobinuria D) Nephrotic syndrome
A) They decrease the blood viscosity B) They stimulate procoagulant secretion C) They cause endothelial injury D) They cause systemic dehydration
A) Frequent exercise B) Low altitude living C) High-fiber diet D) Prolonged bed rest
A) D-dimer B) White blood cell count C) Troponin test D) Liver function test
A) Aspirin B) Ibuprofen C) Warfarin D) Acetaminophen
A) Blood transfusion B) Chest tube insertion C) Temporary vena cava filter D) Lung transplant
A) Hemoptysis B) Tachypnea C) Cyanosis D) Dyspnea
A) Warfarin B) Heparin C) Direct-acting oral anticoagulants D) Tissue plasminogen activator
A) About 15% B) Nearly 90% C) Less than 1% D) 50%
A) The Geneva rule group B) The PIOPED investigators C) Philip Steven Wells D) The 64-slice MDCT researchers
A) High probability B) Confirmed PE C) Low probability D) Moderate probability
A) 1.5 points B) 2.0 points C) 1.0 points D) 3.0 points
A) 1.0% B) 21.9% C) 5.0% D) 97.4%
A) PERC rule B) PIOPED recommendation C) Wells score D) Geneva rule
A) Elderly patients B) Pregnant patients C) Patients with high blood pressure D) Patients with chronic obstructive pulmonary disease
A) Planar two-dimensional imaging B) Fluoroscopy C) SPECT D) Chest X-ray
A) Prolonged PR interval B) ST elevation in V5-V6 C) S1Q3T3 D) Left bundle branch block
A) Sinus tachycardia B) Atrial fibrillation C) Inverted T waves in V1-V4 D) Complete heart block
A) Sinus bradycardia B) Normal sinus rhythm C) QRS narrowing D) Atrial fibrillation
A) Beta-blocker administration B) Diuretic monotherapy C) Thrombolysis D) Antibiotic therapy
A) White blood cell count B) C-reactive protein C) Creatinine D) Brain natriuretic peptide
A) Checking for pleurisy B) Prognosis assessment C) Determining lung volume D) Diagnosing pneumonia
A) Trousseau's sign B) Virchow's sign C) McConnell's sign D) Homan's sign
A) 25% B) 94% C) 77% D) 50%
A) Only if they are under 18 years old B) Only if they are asymptomatic C) Yes D) No
A) Troponins B) Albumin C) Glucose D) Hemoglobin
A) Bed rest and elevation B) Anticoagulant therapy C) Surgical removal of the embolus D) Long-term aspirin therapy
A) Warfarin B) Fondaparinux C) Aspirin D) Heparin
A) Aspirin B) LMWH C) Dabigatran D) Warfarin
A) 3–6 months B) 1 month C) 10–12 months D) 1 week
A) 10 years B) 1 month C) 6 months D) 2 years
A) Hypotension B) Itching C) Increased appetite D) Mild headache
A) 26% B) 10% C) 50% D) 5%
A) Oxford University Hospital B) London General Hospital C) Cambridge Medical Center D) Bristol Royal Infirmary
A) Type 1 diabetes B) COPD C) Thyroid disease D) Allergies
A) The data was fabricated B) Old technology detected only severe PEs C) The patients were all children D) The sample size was too large
A) High blood glucose B) Increased white blood cell count C) Low hemoglobin D) Elevated cardiac enzymes
A) Surgery B) Osmosis C) Fibrinolysis D) Radiation
A) 11 B) 15 C) 5 D) 10
A) 40,000 B) 250,000 C) 10,000 D) 100,000 |